Anzeige
Erschienen in:
20.08.2018 | Original Scientific Report
Challenges of Costing a Surgical Procedure in a Lower–Middle-Income Country
Erschienen in: World Journal of Surgery | Ausgabe 1/2019
Einloggen, um Zugang zu erhaltenAbstract
Background
It is vital to enquire into cost of health care to ensure that maximum value for money is obtained with available resources; however, there is a dearth of information on cost of health care in lower–middle-income countries (LMICs). Our aim was to develop a reproducible costing method for three routes of hysterectomy in benign uterine conditions: total abdominal (TAH), non-descent vaginal (NDVH) and total laparoscopic hysterectomy (TLH).
Methods
A societal perspective with a micro-costing approach was applied to find out direct and indirect costs. A total of 147 patients were recruited from a district general hospital (Mannar) and a tertiary care hospital (Ragama). Costs incurred from preoperative period to convalescence included direct costs of labour, equipment, investigations, medications and utilities, and indirect costs of out-of-pocket expenses, productivity losses, carer costs and travelling. Time-driven activity-based costing was used for labour, and top-down micro-costing was used for utilities.
Results
The total cost [(interquartile range), number] of TAH was USD 339 [(308–397), n = 24] versus USD 338 [(312–422), n = 25], NDVH was USD 315 [(316–541), n = 23] versus USD 357 [(282–739), n = 26] and TLH was USD 393 [(338–446), n = 24] versus USD 429 [(390–504), n = 25] at Mannar and Ragama, respectively. The direct cost of TAH, NDVH and TLH was similar between the two centres, whilst indirect cost was related to the setting rather than the route of hysterectomy.
Conclusions
The costing method used in this study overcomes logistical difficulties in a LMIC and can serve as a guide for clinicians and policy makers in similar settings.
Trial registration
The study was registered in the Sri Lanka clinical trials registry (SLCTR/2016/020) and the International Clinical Trials Registry Platform (U1111-1194-8422) on 26 July 2016.